Cyclerion Announces Transformational Relaunch as a Neuropsychiatric Company

Benzinga
2025.09.23 21:02
portai
I'm PortAI, I can summarize articles.

CAMBRIDGE, Mass., Sept. 23, 2025 ( GLOBE NEWSWIRE ) -- Cyclerion Therapeutics, Inc. today announced that it has entered into a licensing agreement with the Massachusetts Institute of Technology ( "MIT" ) , securing the intellectual property that will serve as the cornerstone of its strategic ...

Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer